Technical Analysis for AEZS - Aeterna Zentaris Inc

Grade Last Price % Change Price Change
F 1.17 0.86% 0.010
AEZS closed up 0.86 percent on Friday, May 7, 2021, on 10 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical AEZS trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Hammer Candlestick Bullish 0.86%
Lizard Bullish Bullish Day Trade Setup 0.86%
Wide Bands Range Expansion 0.86%
Fell Below 20 DMA Bearish 0.86%
Earnings Movers Other 0.86%
Wide Bands Range Expansion 0.86%
20 DMA Support Bullish -9.30%
Older End-of-Day Signals for AEZS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Aeterna Zentaris Inc Description

Aeterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and women's health. The Company operates through the biopharmaceutical segment. The Company is engaged in drug development activities and in the promotion of products for others. The Company's principal product candidates are Zoptrex (zoptarelin doxorubicin) and Macrilen (macimorelin) in oncology and endocrinology. The Company focuses on its product candidates Zoptrex and Macrilen, which are in Phase III clinical development, and on a luteinizing hormone-releasing hormone (LHRH)-disorazol Z conjugate (AEZS-138), which is in pre-clinical development in oncology and is available for partnering. The Company's direct and indirect subsidiaries include AEZS GmbH, Zentaris IVF GmbH and Aeterna Zentaris, Inc.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Specialty Pharma Pharmaceutical Clinic Drug Biotechnology Leasing Life Sciences Biopharmaceutical Oncology Drug Development Peptides Hormone

Is AEZS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.63
52 Week Low 0.37
Average Volume 482,876
200-Day Moving Average 0.889
50-Day Moving Average 1.364
20-Day Moving Average 1.221
10-Day Moving Average 1.282
Average True Range 0.124
ADX 15.49
+DI 22.495
-DI 20.716
Chandelier Exit (Long, 3 ATRs ) 1.067
Chandelier Exit (Short, 3 ATRs ) 1.413
Upper Bollinger Band 1.404
Lower Bollinger Band 1.037
Percent B (%b) 0.36
BandWidth 30.070
MACD Line -0.043
MACD Signal Line -0.043
MACD Histogram 0.0004
Fundamentals Value
Market Cap 73.33 Million
Num Shares 62.7 Million
EPS -0.75
Price-to-Earnings (P/E) Ratio -1.56
Price-to-Sales 9.61
Price-to-Book 1.71
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.230
Resistance 3 (R3) 1.230 1.210 1.220
Resistance 2 (R2) 1.210 1.195 1.210 1.217
Resistance 1 (R1) 1.190 1.185 1.180 1.190 1.213
Pivot Point 1.170 1.170 1.165 1.170 1.170
Support 1 (S1) 1.150 1.155 1.140 1.150 1.127
Support 2 (S2) 1.130 1.145 1.130 1.123
Support 3 (S3) 1.110 1.130 1.120
Support 4 (S4) 1.110